Universal Health Coverage in the Philippines : Progress on Financial Protection Goals
Providing protection against the financial risk of high out-of-pocket health spending is one of the main goals of the Philippines’ health strategy. Yet, as this paper shows using eight household surveys, health spending increased by 150 percent (re...
Main Authors: | , |
---|---|
Format: | Working Paper |
Language: | English en_US |
Published: |
World Bank, Washington, DC
2015
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/2015/05/24450100/universal-health-coverage-philippines-progress-financial-protection-goals http://hdl.handle.net/10986/21990 |
Summary: | Providing protection against the
financial risk of high out-of-pocket health spending is one
of the main goals of the Philippines’ health strategy. Yet,
as this paper shows using eight household surveys, health
spending increased by 150 percent (real) from 2000 to 2012,
with the sharpest increases occurring in recent years. The
main driver of health spending is medicines, accounting for
almost two-thirds of total health spending, and as much as
three-quarters among the poor. The incidence of catastrophic
payments has trebled since 2000, from 2.5 to 7.7 percent.
The percentage of people impoverished by health spending has
also increased and, in 2012, out-of-pocket spending on
health added 1.5 percentage points to the poverty rate. In
light of these findings, recent policies to enhance
financial risk protection—such as the expansion of
government-subsidized health insurance for the poor, a
deepening of the benefit package, and provider payment
reform aimed at cost-containment—are to be applauded.
Between 2008 and 2013, self-reported health insurance
coverage increased across all quintiles and its distribution
became more pro-poor. To speed progress toward financial
protection goals, possible quick wins could include issuing
health insurance cards for the poor to increase awareness of
coverage and introducing a fixed copayment for non-poor
members. Over the medium term, complementary investments in
supply-side readiness are essential. Finally, an in-depth
analysis of the pharmaceutical sector would help to shed
light on why medicines continue to place such a large
financial burden on households. |
---|